This article examines the features and applications of Trioctylphosphine Oxide, 99% TOPO including the physical and chemical properties supplied by Strem Chemicals
http://www.azonano.com/article.aspx?ArticleID=2874 | 13 May 2011
This case study compares dynamic light scattering to other methods such as transmission electron microscopy and x-ray diffraction for the determination of particle size for Cadmium Selenide...
http://www.azonano.com/article.aspx?ArticleID=1098 | 20 Jan 2005
Atomic force microscopes (AFMs) use a piezoelectric crystal to actuate the positioning scanner. Creep and hysteresis errors however limit the capability of measuring the sample topography. This...
http://www.azonano.com/article.aspx?ArticleID=2990 | 13 Mar 2012
The Centre of Excellence in Metrology for Micro and Nano Technologies (CEMMNT) provides access to equipment and expertise to accelerate product commercialisation. This article examines Wafer Crystal...
http://www.azonano.com/article.aspx?ArticleID=2062 | 12 Feb 2008
FRT presents a new profilometer at this year's CONTROL 2009 in Stuttgart.
The optical profiler
has been optimized for the non-destructive measurement of surfaces. The MicroSpy
http://www.azonano.com/news.aspx?newsID=11223 | 30 Apr 2009
Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that CRLX101 has achieved its primary efficacy endpoint in an ongoing single-arm Phase 2...
http://www.azonano.com/news.aspx?newsID=29151 | 15 Jan 2014
Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced the publication of translational data on the company's lead candidate, CRLX101, currently in...
http://www.azonano.com/news.aspx?newsID=28255 | 11 Sep 2013
Cerulean Pharma Inc., a leader in Dynamic Tumor Targeting™, today announced that Christopher D. T. Guiffre, President and Chief Executive Officer, will present at the 14th Annual Needham...
http://www.azonano.com/news.aspx?newsID=32570 | 16 Apr 2015
Crystalline nanoparticle arrays and superlattices can be synthesized with perfectly defined geometries using appropriate electrostatic, hydrogen bonding or biological recognition interactions.
http://www.azonano.com/article.aspx?ArticleID=3217 | 26 Feb 2013
Cerulean Pharma Inc., a clinical stage company developing nanoparticle-drug conjugates (NDCs), today announced that the first patient has been dosed in a trial exploring a dose-intensive schedule for...
http://www.azonano.com/news.aspx?newsID=33993 | 20 Oct 2015